The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology
- Earn up to 28.25 CME credits | ABIM
Media Formats Choose Video Option:Online – $1,395Online + USB – $1,545Online + USB + Printed Syllabus – $1,770
Starting at$1,395.00Current Stock:
Quick Facts
a CMEinfo video production
Accredited by:Oakstone Publishing
Content by:Brigham and Women’s Hospital and
Dana-Farber Cancer Institute
Course Director:
Wendy Y. Chen, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Credits:Earn a maximum of 28.25 AMA PRA Category 1 Credits™ and 28.25 ABIM MOC points
Overview
Can’t Miss Topics in Oncology CME
Gain essential knowledge with The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology. This dynamic online CME course delivers the latest insights in oncology management through expert-led, case-based presentations designed to strengthen clinical decision-making and board exam readiness. Take advantage of continuing medical education focused on:
- Infections in Cancer Patients
- Multiple Myeloma
- Waldenstrom Macroglobulemia and Amyloidosis
- Head and Neck Cancers
- Management of Non Small Cell Lung Cancer
- Carcinoid and Neuroendocrine Tumors
- Novel Approaches to Esophageal and Gastric Cancer Management
- and many more…
This program is also available as part of the combined Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology CME course found here.
Topics / Speakers
Molecular Genetics of Cancer – Marios Giannakis, MD, PhD
Infections in Cancer Patients – Lindsey Baden, MD
Opioid Prescribing for Cancer-Related Pain – Kate M. Lally, MD
Communication – The Key to Excellence in End-of-Life Care – Eilann C. Santo, MD, MPH
Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
Biology of Acute Leukemia and Myelodysplastic Syndromes – Zuzana Tothova, MD, PhD
The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now – Daniel J. DeAngelo, MD, PhD
Myelodysplastic Syndrome – Eric S. Winer, MD
Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
Myeloproliferative Syndromes – Joan-Chi How, MD
Multiple Myeloma – Kenneth C. Anderson, MD
Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD
Low Grade Lymphomas – Caron A. Jacobson, MD
Non-Hodgkin’s Lymphona – Diffuse Large B-Cell and Burkitt – Eric D. Jacobsen, MD
Non-Hodgkin Lymphoma – Mantle Cell and T-Cell – Eric D. Jacobsen, MD
Hodgkin’s Lymphoma – Reid W. Merryman, MD
Diagnosis and Treatment of CLL and Related B-Cell Malignancies – Matthew S. Davids, MD
Head and Neck Cancer – Kartik Sehgal, MD
Thyroid Cancer – Kartik Sehgal, MD
Natural History, Screening, and Small Cell Lung Cancer – Jacob M. Sands, MD
Management of Stage I-III – Non Small Cell Lung Cancer – Julia Rotow, MD
Management of Metastatic – Non Small Cell Lung Cancer – Julia Rotow, MD
Mesothelioma and Thymic Malignancies – David Kwiatkowski, MD, PhD
Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD
Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD
Pancreatic Cancer – Brian M. Wolpin, MD
Hepatobiliary Cancers Board Review – James M. Cleary, MD, PhD
Management of Localized Colorectal Cancer – Douglas A. Rubinson, MD, PhD
Metastatic Colorectal Cancer – Leah H. Biller, MD
Gastrointestinal Cancer Genetics – Asaf Maoz, MD
Prostate, Bladder, and Testicular Cancer – Mark M. Pomerantz, MD
Key Updates in Urothelial Carcinoma – Bradley A. McGregor, MD
Key Updates in Renal Cell Carcinoma – Bradley A. McGregor, MD
Prostate Cancer Part I – Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD
Prostate Cancer Part II – Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD
Melanoma – F. Stephen Hodi, MD
Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD
Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD
Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
Neuro-oncology – David A. Reardon, MD
Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
Multimodality Therapy for Early Stage Breast Cancer – Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
Multimodality Therapy for Early Stage Breast Cancer – Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
Management of Metastatic Breast Cancer – Adrienne G. Waks, MD
Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
Faculty
Course Director
Wendy Y. Chen, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Faculty
Kenneth C. Anderson, MD
Kraft Family Professor of Medicine
Harvard Medical School
Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Lindsey Baden, MD
Elizabeth G. and Gary J. Nabel Family Professor
Professor of Medicine
Harvard Medical School
Director Immunocompromised Service
Division of Infectious Diseases
Department of Medicine
Brigham and Women’s Hospital
Leah H. Biller, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Harold J. Burstein, MD, PhD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Jorge J. Castillo, MD
Associate Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Jennifer Ang Chan, MD
Associate Professor of Medicine
Harvard Medical School
Director, Program in Neuroendocrine and Carcinoid Tumors
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Atish D. Choudhury, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
James M. Cleary, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Director, Clinical Research,
Division of Gastrointestinal Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Matthew S. Davids, MD
Associate Professor of Medicine
Harvard Medical School
Clinical Research Director
Division of Lymphoma
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Daniel J. DeAngelo, MD, PhD
Professor of Medicine
Harvard Medical School
Chief of the Division of Leukemia
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Peter C. Enzinger, MD
Associate Professor of Medicine
Harvard Medical School
Director, Center for Esophageal and Gastric Cancer
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Judy E. Garber, MD, MPH
Professor of Medicine
Harvard Medical School
Chief, Division of Cancer Genetics and Prevention
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Suzanne George, MD
Associate Professor of Medicine
Harvard Medical School
Chief, Division of Sarcoma
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Marios Giannakis, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Department of Medical Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
F. Stephen Hodi, MD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Joan-Chi How, MD
Assistant Professor of Medicine
Harvard Medical School
Chief of Hematology
Brigham and Women’s Faulkner Hospital
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Eric D. Jacobsen, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director
Adult Lymphoma Program and Institute Physician
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Caron A. Jacobson, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Panagiotis A. Konstantinopoulos, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Director Translational Research Gynecologic Oncology Program
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
David Kwiatkowski, MD, PhD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Kate M. Lally, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director, Adult Palliative Care
Department of Psychosocial Oncology and Palliative Care
Dana-Farber Cancer Institute
Division of Palliative Medicine
Department of Medicine
Brigham and Women’s Hospital
Marlise R. Luskin, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Asaf Maoz, MD
Instructor in Medicine
Harvard Medical School
Division of Genetics and Prevention and Gastrointestinal Cancer Center
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Ursula A. Matulonis, MD
Professor of Medicine
Harvard Medical School
Chief, Division of Gynecologic Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Bradley A. McGregor, MD
Professor of Medicine
Harvard Medical School
Director of Clinical Research
Lank Center for GU Oncology
Marra Lochiatto Investigatorship in Kidney Cancer Research
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Reid W. Merryman, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Ann H. Partridge, MD, MPH
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Mark M. Pomerantz, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
David A. Reardon, MD
Professor of Medicine
Harvard Medical School
Clinical Director
Center for Neuro-Oncology and Alperin Family Chair in Neuro-Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Julia Rotow, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director
Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Douglas A. Rubinson, MD, PhD
Assistant Professor of Medicine
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Jacob M. Sands, MD
Assistant Professor of Medicine
Harvard Medical School
Thoracic Oncology Program
Dana-Farber Cancer Institute
Eilann C. Santo, MD, MPH
Instructor in Medicine
Harvard Medical School
Psychosocial Oncology and Palliative Care
Medical Director, HeartPal
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Kartik Sehgal, MD
Instructor of Medicine
Harvard Medical School
Director of Clinical Research
Head and Neck Oncology
Director, Thyroid Cancer Center
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Robert J. Soiffer, MD
Worthington and Margaret Collette
Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Zuzana Tothova, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Adrienne G. Waks, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Eric S. Winer, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director, Division of Adult Leukemia
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Brian M. Wolpin, MD
Professor of Medicine
Harvard Medical School
Director, Gastrointestinal Cancer Center
Director, Hale Family Center for Pancreatic Cancer
Robert T. & Judith B. Hale Chair in Pancreatic Cancer
Department of Medical Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Accreditation / Pass Guarantee
Accreditation
Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
Oakstone Publishing designates this enduring material for a maximum of 28.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 28.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Date of Original Release: March 15, 2025
Termination Date: March 14, 2028
CME credit is awarded upon successful completion of a course evaluation and post-test.
Learning Objectives
At the conclusion of this activity, the participant will be able to:
- Apply current/recommended oncology guidelines in clinical practice
- Perform differential diagnosis of complex clinical presentations related to oncologic disorders
- Identify/apply current therapeutic options for specific oncologic disorders
- Review and interpret up-to-date literature relevant to clinical practice in oncology
- Demonstrate knowledge of pathophysiology as it applies to management of oncology disorders
- Apply knowledge gained to the ABIM certification/recertification oncology examinations
Intended Audience
The activity was planned for fellows/trainees, practicing oncology specialists (MDs), and other professional affiliates (internists with an interest in oncology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the areas of oncology medicine.
Board Pass Guarantee
We’re Committed to Your Success. Oakstone stands behind the quality of its board review programs. If you complete a course and do not pass your board examination, we will provide extended access to the content or credit toward the purchase of a future board review program in accordance with our CME Board Pass Guarantee policy.
This pass guarantee is a product policy offered by Oakstone and is independent of CME accreditation. Accreditation pertains only to the educational activity and does not guarantee examination outcomes.
SKU: MOX558E0
About Oakstone
About Ebix
Ebix | Oakstone Publishing
1 Ebix Way
Johns Creek, GA 30097
Copyright © 2026 Ebix Inc. Terms of Service | Privacy Policy | Sitemap